CanSino Biologics Inc.'in temel mali tabloları nelerdir?
06185.HK'ün temel finansal oranları nelerdir?
CanSino Biologics Inc.'in geliri segment veya coğrafya bazında nasıl dağılıyor?
CanSino Biologics Inc. kârlı mı?
CanSino Biologics Inc.'in herhangi bir yükümlülüğü var mı?
CanSino Biologics Inc.'in tedavüldeki hisse sayısı kaçtır?
Önemli İstatistikler
Önceki Kapanış
$34.26
Açılış fiyatı
$34.02
Günün Aralığı
$33.58 - $34.84
52 haftalık aralık
$25.25 - $56.55
İşlem hacmi
548.6K
Ort.Hacim
742.0K
EPS (TTM)
-0.75
Dividend yield
--
Piyasa Değeri
$4.5B
CANSINOBIO nedir?
CanSino Biologics Inc is a CN-based company operating in Biotechnology industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,105 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The firm is also engaged in the research and development of pharmaceutical production processes. The firm conducts its business in the domestic and overseas markets.